HomeAI · summaries
Storia in 5 fonti
How Trump's psychedelics executive order could unlock stalled cannabis reform
The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs.
- ·
scmp.com
Trump signs order to speed up review of psychedelics
This would expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat PTSD.
